Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease modelsLinhui Julie Su, Susan Lindquist, Tiago F. Outeiro et al.|Disease Models & Mechanisms|2009Cited by 176
Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease modelsJ. Brucker Nourse, Guy A. Caldwell|Proceedings of the National Academy of Sciences|2023Cited by 12
Integrated Regulation of Dopaminergic and Epigenetic Effectors of Neuroprotection in Parkinson’s Disease ModelsJ. Brucker Nourse, Guy A. Caldwell|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0